ZDHHC5 Activators encompasses a range of chemical compounds that are selected based on their to indirectly modulate the functional activity of ZDHHC5, a zinc finger DHHC-type palmitoyltransferase. Compounds like 2-Bromopalmitate could enhance ZDHHC5 activity through compensatory feedback mechanisms in the palmitoylation pathway. Similarly, the availability of substrates such as Palmitic Acid is crucial for ZDHHC5's enzymatic activity, suggesting that increased substrate levels could enhance its function. Cerulenin and Fenretinide, by modifying fatty acid synthesis and lipid metabolism, respectively, might indirectly affect ZDHHC5 activity, given the enzyme's role in lipid modification of proteins.
Moreover, compounds like Curcumin and Anacardic Acid, which influence a wide array of cellular signaling pathways, could indirectly impact ZDHHC5's activity through their broad biological effects, altering the cellular context in which ZDHHC5 operates. Additionally, Triciribine, LY294002, PF-04691502, and Wortmannin points to the indirect modulation of ZDHHC5 activity through the PI3K/AKT and mTOR signaling pathways. These pathways are integral to various aspects of cellular signaling and metabolism, which could intersect with ZDHHC5's function in palmitoylation. Rapamycin and Simvastatin, targeting cholesterol biosynthesis, further highlight the indirect influences on ZDHHC5 activity. These compounds might alter the cellular lipid environment or signaling pathways, thereby enhancing the role of ZDHHC5 in protein palmitoylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
A substrate for palmitoylation; could enhance ZDHHC5 activity by providing increased substrate availability. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Affects various signaling pathways and could influence ZDHHC5 activity indirectly through its broad biological impacts. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Histone acetyltransferase inhibitor; might affect ZDHHC5 indirectly by altering protein interactions and signaling pathways. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor; could affect ZDHHC5 activity indirectly via PI3K/AKT signaling pathways related to cellular signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor; could alter signaling pathways potentially affecting ZDHHC5's role in palmitoylation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor; could indirectly enhance ZDHHC5 activity by affecting mTOR-related signaling and lipid metabolism. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor; could indirectly affect ZDHHC5 through its role in signaling pathways involved in lipid metabolism. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
An HMG-CoA reductase inhibitor; could influence ZDHHC5 activity by altering cholesterol biosynthesis and lipid modification. | ||||||